S. M. Luger
- Hematology top 2%
- Molecular Biology
- Oncology top 10%
- Immunology top 10%
- Genetics top 10%
- Co-authors
- Barry GrimesR. RossiCraig T. JordanSJ SzilvassyGL PhillipsTodd E. MeyerroseMariusz Z. RatajczakAM Gewirtz
- Topics
- Acute Myeloid Leukemia Research (9 papers)Acute Lymphoblastic Leukemia research (4 papers)Chronic Myeloid Leukemia Treatments (3 papers)
- Cited by
- HematologyOncologyGenetics
- Partner nations
- United StatesIsrael
In The Last Decade
S. M. Luger
14 papers receiving 926 citations
Hit Papers
Peers
Comparison fields: 5 of 52
- Hematology 492
- Molecular Biology 407
- Oncology 372
- Immunology 274
- Genetics 141
Countries citing papers authored by S. M. Luger
This map shows the geographic impact of S. M. Luger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. M. Luger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. M. Luger more than expected).
Fields of papers citing papers by S. M. Luger
This network shows the impact of papers produced by S. M. Luger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. M. Luger. The network helps show where S. M. Luger may publish in the future.
Co-authorship network of co-authors of S. M. Luger
This figure shows the co-authorship network connecting the top 25 collaborators of S. M. Luger. A scholar is included among the top collaborators of S. M. Luger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S. M. Luger. S. M. Luger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 3 | |
| 3 | 3 | |
| 4 | 2 | |
| 5 | 12 | |
| 6 | 1 | |
| 7 | 1 | |
| 8 | The interleukin-3 receptor alpha chain is a unique marker for human acute myelogenous leukemia stem cellsbreakdown → | 623 |
| 9 | 12 | |
| 10 | 19 | |
| 11 | 64 | |
| 12 | 78 | |
| 13 | 115 | |
| 14 | 15 |
About S. M. Luger
S. M. Luger is a scholar working on Hematology, Immunology and Genetics, having authored 14 papers that have together received 949 indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (9 papers), Acute Lymphoblastic Leukemia research (4 papers) and Chronic Myeloid Leukemia Treatments (3 papers). The work is most often cited by research in Hematology (492 citations), Oncology (372 citations) and Genetics (141 citations). S. M. Luger has collaborated with scholars based in United States and Israel. Frequent co-authors include Barry Grimes, R. Rossi, Craig T. Jordan, SJ Szilvassy, GL Phillips, Todd E. Meyerrose, Mariusz Z. Ratajczak, AM Gewirtz, Lucia Catani and Nobuko Hijiya. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.